Lukas Vogt

About

With over a decade of experience in the pharmaceutical sector, currently leading galenical development at Develco Pharma Schweiz AG. Skilled in late-phase formulation development and oral solid dosage forms, bringing expertise in lifesciences, biotechnology, and the pharmaceutical industry. Previous roles at FHNW and Novartis honed expertise in formulation project leadership and scientific research. Dedicated to advancing therapeutic technologies, fostering innovation, and delivering impactful solutions aligned with organizational goals. Collaborative and driven, aiming to enhance pharmaceutical development while contributing diverse perspectives to team success.

Experience

• Head of Galenical Development at Develco Pharma Schweiz AG
  Jan 2023 - Present · 3 yrs 7 mos

• Scientific Associate at University of Applied Sciences and Arts Northwestern Switzerland FHNW
  Dec 2019 - Dec 2022 · 3 yrs 1 mo

• Fellow - Formulation Project Leader at Novartis
  Oct 2017 - Nov 2019 · 2 yrs 2 mos

  Late Phase Formulation Development - Oral Solid Dosage Forms

• Research Scientist - Formulation Development Manager at Elanco
  Jul 2016 - Sep 2017 · 1 yr 3 mos

  - Development and up-scaling of solid dosage forms - Extrusion process and equipment engineering - Process transfer - Product stewardship

• Formulation Development Manager at Actelion
  Oct 2015 - Jun 2016 · 9 mos

  - Development and up-scaling of solid oral dosage forms - Manufacturing of Clinical Trial Material